1. Home
  2. OCFC vs SPRY Comparison

OCFC vs SPRY Comparison

Compare OCFC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanFirst Financial Corp.

OCFC

OceanFirst Financial Corp.

HOLD

Current Price

$19.35

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$9.78

Market Cap

946.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCFC
SPRY
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
946.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
OCFC
SPRY
Price
$19.35
$9.78
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$21.60
$31.25
AVG Volume (30 Days)
343.7K
2.4M
Earning Date
01-22-2026
11-10-2025
Dividend Yield
4.14%
N/A
EPS Growth
N/A
N/A
EPS
1.30
N/A
Revenue
$378,558,000.00
$142,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.51
$193.13
P/E Ratio
$14.87
N/A
Revenue Growth
N/A
5459.66
52 Week Low
$14.29
$6.66
52 Week High
$20.76
$18.90

Technical Indicators

Market Signals
Indicator
OCFC
SPRY
Relative Strength Index (RSI) 61.62 58.71
Support Level $18.67 $9.02
Resistance Level $19.66 $9.76
Average True Range (ATR) 0.59 0.64
MACD 0.15 0.28
Stochastic Oscillator 86.97 92.30

Price Performance

Historical Comparison
OCFC
SPRY

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: